Skip to content

THe elucidation of risk factors for Cognitive Decline/ Frailty in Diabetes and Obesity-To establish effective early detection and prognosis prediction methods-

Elucidation of risk factors for Cognitive Decline/ Frailty in Diabetes and Obesity-To establish effective early detection and prognosis prediction methods- - JOMS/J-DOS3

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000051269
Enrollment
400
Registered
2023-07-01
Start date
2023-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type2 diabetes mellitus, obesity

Interventions

None listed

Sponsors

Clinical Research Institute,National Hospital Organization, Kyoto Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients shall meet all of the following criteria 1)Disease and diagnosis: Patients who meet one or both of the following criteria Patients diagnosed as type 2 diabetes mellitus. Obesity:BMI 25 kg/m2 and upwards(according to the guidelines of the Japan Society for the Study of Obesity) 2)Age: Patients who are 40 years of age or older at the time of consent 3)Gender:Any gender 4)Patients attending outpatient clinics or hospitalized in departments related to lifestyle-related diseases(internal medicine, diabetes, endocrinology and metabolism, general internal medicine, cardiovascular medicine, etc.)at National Hospital Organization facilities nationwide 5)Documented consent of the subject or the surrogate: Patients who have given written consent of their own free will or that of their surrogate.

Exclusion criteria

Exclusion criteria: 1) Patients with secondary obesity(adrenal gland disease, etc.) 2) Patients with severe hepatic dysfunction or cirrhosis 3) Patients with serious renal dysfunction (serum creatinine level:3.0 mg/dl or higher) 4) Female patients who are pregnant or may become pregnant 5) Patients who are judged to be inappropriate to participate in this study by the principal investigator and research coordinators.

Design outcomes

Primary

MeasureTime frame
Cognitive function test: MMSE(MCI: 24-27 points)and Simple Frail Questionnaire (Frail: 3 points or more).We will check them every 1 year for 5years.

Secondary

MeasureTime frame
1)Cognitive function tests: a)Cognitive function test: MMSE(Dementia:23 points or less, MCI:24-27 points) b)Imaging tests: brain MRI(T1-weighted, T2-weighted, FLAIR, diffusion-weighted, T2star, MRA) 2)Frailty a)Simple Frail Questionnaire (Frail: 3 points or more, Pre-Frail: 2 points) b)Ministry of Health, Labour and Welfare: Basic Checklist for Frailty 3)Event occurrence a)Combined cerebrovascular events:cardiovascular death and nonfatal acute myocardial infarction requiring hospitalization, nonfatal stroke, acute coronary syndrome, aortic and peripheral artery disease, heart failure, angioplasty for coronary artery, aorta and peripheral artery. b)All-cause mortality

Countries

Japan

Contacts

Public ContactNoriko Asahara

National Hospital Organization, Kyoto Medical Center Department of Endocrinology, Metabolism and Hypertension Research, Clinical Research Institute

nsatoh@kuhp.kyoto-u.ac.jp075-641-9161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026